Point72 Asset Management
HZNP

Point72 Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Point72 Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,000
Closed -$3.47M – 3024
2023
Q3 		$3.47M Sell
30,000
-10,000
-25% -$1.07M 0.01% 997
2023
Q2 		$4.11M Buy
+40,000
New +$4.22M 0.01% 871
2017
Q4 		– Sell
-500,000
Closed -$6.34M – 1187
2017
Q3 		$6.34M Buy
+500,000
New +$6.36M 0.03% 499

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Asset Management's HZNP Position: Q4 2023 in Review

Point72 Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 175,000 shares — an estimated $20.2M sold.

Point72 Asset Management first reported a position in HZNP in Q3 2014 and held it in 21 quarters. The position peaked at $130M in Q3 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Point72 Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 175,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $20.2M.
  • Point72 Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 21 quarters.
  • Point72 Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $130M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.